Wet Macular Degeneration Market

Wet macular degeneration is a chronic eye disorder that induces vague vision or a blind spot in the patient's visual field.

Wet Macular Degeneration Market contains market size and forecasts of Wet Macular Degeneration in Global, including the following market information:

• Global Wet Macular Degeneration Market Revenue, 2017-2022, 2023-2028, ($ millions)
• Global top five companies in 2021 (%)

The global Wet Macular Degeneration market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

by Drug Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Wet Macular Degeneration include Pfizer Inc., F. Hoffmann-La Roche AG, Regeneron Pharmaceuticals, Inc., Novartis AG, Bausch Health Companies Inc., Apellis Pharmaceuticals Inc., GlaxoSmithKline plc, Ophthotech Corporation and Gilead Sciences, Inc., etc. In 2021, the global top five players have a share approximately % in terms of revenue.

We surveyed the Wet Macular Degeneration companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Wet Macular Degeneration Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Wet Macular Degeneration Market Segment Percentages, by Type, 2021 (%)

by Drug

• Lucentis
• Eylea
• Avastin
• Others

by Route of Administration

• Intravitreal
• Intravenous

Global Wet Macular Degeneration Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Wet Macular Degeneration Market Segment Percentages, by Application, 2021 (%)

• Hospitals
• Clinics
• Research Institutes
• Academic Institutes

Global Wet Macular Degeneration Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Wet Macular Degeneration Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

• Key companies Wet Macular Degeneration revenues in global market, 2017-2022 (estimated), ($ millions)
• Key companies Wet Macular Degeneration revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Pfizer Inc.
• F. Hoffmann-La Roche AG
• Regeneron Pharmaceuticals, Inc.
• Novartis AG
• Bausch Health Companies Inc.
• Apellis Pharmaceuticals Inc.
• GlaxoSmithKline plc
• Ophthotech Corporation
• Gilead Sciences, Inc.
• Alcon
• Genzyme Corporation
• Boehringer Ingelheim GmbH
• EyeGate Pharmaceuticals, Inc.
• EyeCyte, Inc.
• PanOptica Inc